← 返回

氧化黑色素瘤抗原促进细胞毒性 T 细胞亚群的活化和增殖

英文原题:Oxidized Melanoma Antigens Promote Activation and Proliferation of Cytotoxic T-Cell Subpopulations.

查看英文原题

Oxidized Melanoma Antigens Promote Activation and Proliferation of Cytotoxic T-Cell Subpopulations.

PubMed 2024/07/03(内容时间) Adv Sci (Weinh) Q1 · IF 14.1(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

越来越多的证据表明,活性氧和活性氮(RONS)在调节抗肿瘤免疫效应和免疫抑制中发挥作用。RONS修饰生物分子,并诱导蛋白质上的氧化翻译后修饰(oxPTM),从而能够警示吞噬细胞。

然而,通过技术手段使蛋白质氧化是否以及如何成为促进抗肿瘤免疫和治疗的策略尚不清楚。为此,本研究利用冷气体等离子体技术同时产生多种RONS,以氧化两种黑色素瘤相关抗原MART和PMEL。质谱测定显示,冷等离子体氧化的MART(oxMART)和PMEL(oxPMEL)被大量oxPTM修饰。在用存活黑色素瘤细胞攻击前,以氧化MART或PMEL疫苗进行免疫,与细胞因子分泌的显著变化以及肿瘤浸润白细胞(TILs)中T细胞分化的改变相关。oxMART促进了细胞毒性中枢记忆T细胞的活性,而oxPMEL则导致细胞毒性效应T细胞增殖增加。将荷瘤小鼠的脾细胞与B16F10黑色素瘤细胞共孵育后,也观察到类似的T细胞结果。

本研究首次提供了证据,表明两种黑色素瘤相关抗原的氧化修饰在激发抗癌免疫中具有重要性。

展开英文摘要原文

Increasing evidence suggests the role of reactive oxygen and nitrogen species (RONS) in regulating antitumor immune effects and immunosuppression. RONS modify biomolecules and induce oxidative post-translational modifications (oxPTM) on proteins that can alarm phagocytes.

However, it is unclear if and how protein oxidation by technical means could be a strategy to foster antitumor immunity and therapy. To this end, cold gas plasma technology producing various RONS simultaneously to oxidize the two melanoma-associated antigens MART and PMEL is utilized. Cold plasma-oxidized MART (oxMART) and PMEL (oxPMEL) are heavily decorated with oxPTMs as determined by mass spectrometry.

Immunization with oxidized MART or PMEL vaccines prior to challenge with viable melanoma cells correlated with significant changes in cytokine secretion and altered T-cell differentiation of tumor-infiltrated leukocytes (TILs). oxMART promoted the activity of cytotoxic central memory T-cells, while oxPMEL led to increased proliferation of cytotoxic effector T-cells. Similar T-cell results are observed after incubating splenocytes of tumor-bearing mice with B16F10 melanoma cells.

This study, for the first time, provides evidence of the importance of oxidative modifications of two melanoma-associated antigens in eliciting anticancer immunity.

论文信息

作者
Clemen R、Miebach L、Singer D、Freund E、von Woedtke T、Weltmann KD、Bekeschus S
单位
ZIK plasmatis, Leibniz Institute for Plasma Science and Technology (INP), Felix-Hausdorff-Str. 2, 17489, Greifswald, Germany.Germany
文献类型
非美国政府资助研究
期刊
Advanced science (Weinheim, Baden-Wurttemberg, Germany)2024 Sep
原文标识
PubMed 38958560 · DOI 10.1002/advs.202404131